Biologics and Biosimilars Market Report

Global and Region Biologics and Biosimilars Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：161
  • REPORT CODE：GMM881873
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

    Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

    The report details the trend, potential and market size of Biologics and Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biologics and Biosimilarsmarket, defines the market attractiveness level of Biologics and Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biologics and Biosimilars industry, describes the types of Biologics and Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biologics and Biosimilars market and the development prospects and opportunities of Biologics and Biosimilars industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biologics and Biosimilars market in Chapter 13.

    By Player:

    • Gelgen

    • Merck

    • Johnson & Johnson

    • Amgen

    • Novo Nordisk

    • Biotech

    • Roche

    • Pfizer

    • Eli Lilly

    • Ganlee

    • Novartis

    • CP Guojian

    • AbbVie

    • Changchun High Tech

    • Innovent

    • Dong Bao

    • 3sbio

    • Sanofi-Aventis

    By Type:

    • Monoclonal Antibodies

    • Interferon

    • Erythropoietin

    • Insulin

    • Vaccines

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biologics and Biosimilars Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biologics and Biosimilars Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biologics and Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biologics and Biosimilars Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biologics and Biosimilars Market Analysis and Outlook to 2022

    • 7.1 Global Biologics and Biosimilars Consumption (2017-2022)

    • 7.2 United States Biologics and Biosimilars Consumption (2017-2022)

    • 7.3 Europe Biologics and Biosimilars Consumption (2017-2022)

    • 7.4 China Biologics and Biosimilars Consumption (2017-2022)

    • 7.5 Japan Biologics and Biosimilars Consumption (2017-2022)

    • 7.6 India Biologics and Biosimilars Consumption (2017-2022)

    • 7.7 South Korea Biologics and Biosimilars Consumption (2017-2022)

    8 Region and Country-wise Biologics and Biosimilars Market Analysis and Outlook to 2028

    • 8.1 Global Biologics and Biosimilars Consumption Forecast (2022-2028)

    • 8.2 United States Biologics and Biosimilars Consumption Forecast (2022-2028)

    • 8.3 Europe Biologics and Biosimilars Consumption Forecast (2022-2028)

    • 8.4 China Biologics and Biosimilars Consumption Forecast (2022-2028)

    • 8.5 Japan Biologics and Biosimilars Consumption Forecast (2022-2028)

    • 8.6 India Biologics and Biosimilars Consumption Forecast (2022-2028)

    • 8.7 South Korea Biologics and Biosimilars Consumption Forecast (2022-2028)

    9 Global Biologics and Biosimilars Market Outlook by Types and Applications to 2022

    • 9.1 Global Biologics and Biosimilars Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Interferon Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biologics and Biosimilars Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Hemophilia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Biologics and Biosimilars Market Outlook by Types and Applications to 2028

    • 10.1 Global Biologics and Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biologics and Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biologics and Biosimilars Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biologics and Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biologics and Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biologics and Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biologics and Biosimilars Market Competitive Analysis

    • 14.1 Gelgen

      • 14.1.1 Gelgen Company Details

      • 14.1.2 Gelgen Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Gelgen Biologics and Biosimilars Product and Service

    • 14.2 Merck

      • 14.2.1 Merck Company Details

      • 14.2.2 Merck Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Biologics and Biosimilars Product and Service

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Details

      • 14.3.2 Johnson & Johnson Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Johnson & Johnson Biologics and Biosimilars Product and Service

    • 14.4 Amgen

      • 14.4.1 Amgen Company Details

      • 14.4.2 Amgen Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Biologics and Biosimilars Product and Service

    • 14.5 Novo Nordisk

      • 14.5.1 Novo Nordisk Company Details

      • 14.5.2 Novo Nordisk Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk Biologics and Biosimilars Product and Service

    • 14.6 Biotech

      • 14.6.1 Biotech Company Details

      • 14.6.2 Biotech Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biotech Biologics and Biosimilars Product and Service

    • 14.7 Roche

      • 14.7.1 Roche Company Details

      • 14.7.2 Roche Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Roche Biologics and Biosimilars Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Biologics and Biosimilars Product and Service

    • 14.9 Eli Lilly

      • 14.9.1 Eli Lilly Company Details

      • 14.9.2 Eli Lilly Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eli Lilly Biologics and Biosimilars Product and Service

    • 14.10 Ganlee

      • 14.10.1 Ganlee Company Details

      • 14.10.2 Ganlee Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Ganlee Biologics and Biosimilars Product and Service

    • 14.11 Novartis

      • 14.11.1 Novartis Company Details

      • 14.11.2 Novartis Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis Biologics and Biosimilars Product and Service

    • 14.12 CP Guojian

      • 14.12.1 CP Guojian Company Details

      • 14.12.2 CP Guojian Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 CP Guojian Biologics and Biosimilars Product and Service

    • 14.13 AbbVie

      • 14.13.1 AbbVie Company Details

      • 14.13.2 AbbVie Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 AbbVie Biologics and Biosimilars Product and Service

    • 14.14 Changchun High Tech

      • 14.14.1 Changchun High Tech Company Details

      • 14.14.2 Changchun High Tech Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Changchun High Tech Biologics and Biosimilars Product and Service

    • 14.15 Innovent

      • 14.15.1 Innovent Company Details

      • 14.15.2 Innovent Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Innovent Biologics and Biosimilars Product and Service

    • 14.16 Dong Bao

      • 14.16.1 Dong Bao Company Details

      • 14.16.2 Dong Bao Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Dong Bao Biologics and Biosimilars Product and Service

    • 14.17 3sbio

      • 14.17.1 3sbio Company Details

      • 14.17.2 3sbio Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 3sbio Biologics and Biosimilars Product and Service

    • 14.18 Sanofi-Aventis

      • 14.18.1 Sanofi-Aventis Company Details

      • 14.18.2 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Sanofi-Aventis Biologics and Biosimilars Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biologics and Biosimilars

    • Figure Biologics and Biosimilars Picture

    • Table Global Biologics and Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biologics and Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biologics and Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biologics and Biosimilars Consumption by Country (2017-2022)

    • Figure United States Biologics and Biosimilars Consumption and Growth Rate (2017-2022)

    • Table Europe Biologics and Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure China Biologics and Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Japan Biologics and Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure India Biologics and Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biologics and Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics and Biosimilars Consumption Forecast by Country (2022-2028)

    • Figure United States Biologics and Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biologics and Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biologics and Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biologics and Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biologics and Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biologics and Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Hemophilia Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biologics and Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biologics and Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    • Table Gelgen (Foundation Year, Company Profile and etc.)

    • Table Gelgen Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gelgen Biologics and Biosimilars Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Biologics and Biosimilars Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Biologics and Biosimilars Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Biologics and Biosimilars Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Biologics and Biosimilars Product and Service

    • Table Biotech (Foundation Year, Company Profile and etc.)

    • Table Biotech Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotech Biologics and Biosimilars Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Biologics and Biosimilars Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Biologics and Biosimilars Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Biologics and Biosimilars Product and Service

    • Table Ganlee (Foundation Year, Company Profile and etc.)

    • Table Ganlee Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ganlee Biologics and Biosimilars Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Biologics and Biosimilars Product and Service

    • Table CP Guojian (Foundation Year, Company Profile and etc.)

    • Table CP Guojian Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table CP Guojian Biologics and Biosimilars Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Biologics and Biosimilars Product and Service

    • Table Changchun High Tech (Foundation Year, Company Profile and etc.)

    • Table Changchun High Tech Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changchun High Tech Biologics and Biosimilars Product and Service

    • Table Innovent (Foundation Year, Company Profile and etc.)

    • Table Innovent Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innovent Biologics and Biosimilars Product and Service

    • Table Dong Bao (Foundation Year, Company Profile and etc.)

    • Table Dong Bao Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dong Bao Biologics and Biosimilars Product and Service

    • Table 3sbio (Foundation Year, Company Profile and etc.)

    • Table 3sbio Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3sbio Biologics and Biosimilars Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Biologics and Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Biologics and Biosimilars Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US